ADA/NAb Testing & Reporting
Stand-alone NAb assay
New Approach Methodologies (NAM)
In silico/in vitro vs AI/ML prediction
Regulatory Feedback on S/N and 1-Tier
Pre-existing Ab meaningful interpretation
Immunogenicity for: Peptides, oligonucleotide, ADC, Bi/Multispecifics, TCE, Gene therapies, Next-generation biotherapeutics, Novel/complex modalities